Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lin, Li ^a,b   Hutzen, Brian ^b,c   Lee, Hsiu Fang ^d   Peng, Zhengang ^e   Wang, Wenlong ^a   Zhao, Chongqiang ^a   Lin, Huey Jen ^e,f   Sun, Duxin ^d   Li, Pui Kai ^c   Li, Chenglong ^c   Korkaya, Hasan ^g   Wicha, Max S ^g   Lin, Jiayuh ^b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e School of Allied Medical Professions   (United States)

^f UNIVERSITY OF DELAWARE   (United States)

^g UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; HERMES ANTIGEN; PROTEIN INHIBITOR; SHORT HAIRPIN RNA; STAT3 PROTEIN; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ANTHRAQUINONE DERIVATIVE; ISOENZYME; LLL12 COMPOUND; MOLECULAR LIBRARY; RETINAL DEHYDROGENASE; SMALL INTERFERING RNA; STATTIC; SULFONAMIDE; SULFOXIDE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER STEM CELL; CANCER TISSUE; CELL NUCLEUS; CELL PROLIFERATION; CELL SELECTION; CELL SUBPOPULATION; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; BREAST TUMOR; CELL SEPARATION; CELL SURVIVAL; DRUG EFFECTS; DRUG SCREENING; FEMALE; METABOLISM; MOLECULAR LIBRARY; PATHOLOGY; PHARMACOLOGY; PHOSPHORYLATION; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; ANTHRAQUINONES; ANTIGENS, CD24; ANTIGENS, CD44; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CYCLIC S-OXIDES; FEMALE; FLOW CYTOMETRY; HUMANS; ISOENZYMES; MICE, SCID; PHOSPHORYLATION; RETINAL DEHYDROGENASE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMALL MOLECULE LIBRARIES; STAT3 TRANSCRIPTION FACTOR; SULFONAMIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84893511414     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082821     Document Type: Article

References (37)

1. Molofsky A, Pardal R, Morrison S (2004) Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 16: 700-707.
2. Passegue E, Jamieson C, Ailles L, Weissman I (2003) Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proc Natl Acad Sci USA 100: 11842-11849.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
4. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, et al. (2009) Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature. Cancer Res 69: 1302-1313.
5. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome. Cell Stem Cell 1: 555-567.
6. Douville J, Beaulieu R, Balicki D (2009) ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells. Stem Cells Dev 18: 17-25.
7. Germain D, Frank DA (2007) Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin Cancer Res 13: 5665-5669.
8. Turkson J, Jove R (2002) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19: 6613-6626.
9. Bromberg J, Wrzeszczynska M, Devgan G, Zhao Y, Pestell R, et al. (1999) Stat3 as an oncogene. Cell 98: 295-303.
10. Inghirami G, Chiarle R, Simmons WJ, Piva R, Schlessinger K, et al. (2005) New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell Cycle 4: 1131-1133.
11. Buettner R, Mora LB, Jove R (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945-954.
12. Cunha GR, Hayward SW, Wang YZ, Ricke WA (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107: 1-10.
13. Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, et al. (2009) Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 15: 4234-4241.
14. Schust J, Sperl B, Hollis A, Mayer TU, Berg T (2006) Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 13: 1235-1242.
15. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. nature 463: 318-325.
16. Kaptein A, Paillard V, Saunders M (1996) Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J Biol Chem 271: 5961-5964.
17. Lin L, Hutzen B, Li PK, Ball S, Zuo M, et al. (2010) A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppresive Activity in Human Cancer Cells. Neoplasia 12: 39-50.
18. Bhasin D, Cisek K, Pandharkar T, Regan N, Li C, et al. (2008) Design, synthesis, and studies of small molecule STAT3 inhibitors. Bioorg Med Chem Lett 18: 391-395.
19. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, et al. (2006) Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 12: 11-19.
20. Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, et al. (2008) Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem 283: 14665-14673.
21. Landen CN Jr, Lin YG, Armaiz Pena GN, Das PD, Arevalo JM, et al. (2007) Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res 67: 10389-10396.
22. Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, et al. (2006) Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 66: 3188-3196.
23. Grivennikov S, Karin M (2008) Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell 13: 7-9.
24. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, et al. (2004) Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6: R605-615.
25. Fillmore CM, Kuperwasser C (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10: R25.
26. Phillips TM, McBride WH, Pajonk F (2006) The response of CD24 (2/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785.
27. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, et al. (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511.
28. Turkson J, Jove R (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19: 6613-6626.
29. Sherry MM, Reeves A, Wu JK, Cochran BH (2009) STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells. Stem Cells 27: 2383-2392.
30. Wang H, Lathia JD, Wu Q, Wang J, Li Z, et al. (2009) Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth. Stem Cells 27: 2393-2404.
31. Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, et al. (2008) The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res 10: R53.
32. Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, et al. (2008) Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res 14: 8010-8018.
33. Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, et al. (2011) Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 15: 614-624.
34. Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, et al. (2011) The JAK/STAT3 signaling pathway is required for growth of CD44+CD24-stem cell-like breast cancer cells in human tumors. J Clin Invest 121: 44745 doi:44710.41172/JC144745.
35. Dave B, Landis M, Tweardy D, Chang J, Dobrolecki L, et al. (2012) Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model. PLoS One 7: e30207.
36. Villalva C, Martin-Lannerée S, Cortes U, Dkhissi F, Wager M, et al. (2010) STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: A potential for targeted therapy? Int J Cancer. 128: 826-838.
37. Walker S, Nelson E, Zou L, Chaudhury M, Signoretti S, et al. (2009) Reciprocal effects of STAT5 and STAT3 in breast cancer. Mol Cancer Res 7: 966-976.